Ana Rita Fradique

Ana Rita Fradique

Auto-generated profile, based on publicly available information

Ana Rita Fradique

Pediatric Intensive Care Unit, Pediatric Hospital, Unidade Local de Saúde de Coimbra, Coimbra, Portugal

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 June 2026 in Pediatric Critical Care Medicine
Verified
Journal Article
Closed access
AFAna Rita Fradique
Ana Rita Fradique
MFMariana Ferreira
Mariana Ferreira
ARAlexandra Costa Rodrigues
Alexandra Costa Rodrigues
MMMargarida Marques
Margarida Marques
CPCarla Pinto
Carla Pinto
ADAndrea Dias
Andrea Dias
Introduction: We have explored the use of early biomarkers for the timely identification of acute kidney injury (AKI) in critically ill children. Design: Single-center cohort study. Setting: Tertiary medical-surgical PICU in Coimbra, Portugal. Patients: Pediatric patients admitted for longer than 48 hours over a 10-month period during 2024–2025. Interventions: None. Measurements and Results: Among 75 patients (55.3% male; median age 3.9 yr), 22 patients (29.3%) developed AKI (defined by Kidney Disease Improving Global Outcomes criteria) on day 1. On comparing those with or without AKI, urinary neutrophil gelatinase-associated lipocalin (uNGAL) levels were elevated on day 1 ( p < 0.001), day 2 ( p = 0.003), and day 3 ( p = 0.013) in AKI patients. Cystatin-C (Cys-C) was only increased on day 1 ( p = 0.013). Shock ( p < 0.001) and vasoactive drug use ( p = 0.007) were more commonly present in AKI patients, who also had lower albumin ( p = 0.012), platelets ( p = 0.001), and bicarbonate level ( p = 0.032). AKI patients also had higher C-reactive protein (CRP; p = 0.018), procalcitonin ( p = 0.002), and lactate concentration ( p = 0.022). Shock and CRP were associated with greater odds (presented as odds ratio [OR] with 95% CI) of AKI, respectively as: OR, 6.10 (95% CI, 1.50–16.52); p = 0.002; and OR, 1.07 (95% CI, 1.00–1.12); p = 0.022; as well as day 1 Renal Angina Index (RAI; OR, 1.10 [95% CI, 1.03–1.17]; p = 0.005). On day 1, the discrimination performance (using the area under the receiver operating characteristic curve [AUC]) for AKI was good-to-excellent for, respectively: uNGAL, 0.847 (95% CI, 0.74–0.96); p value of less than 0.001; and blood urea nitrogen, 0.848 (95% CI, 0.75–0.95); p value of less than 0.001. Regarding uNGAL, the pretest probability of AKI was 29.3%, and the posttest probability of AKI on finding a uNGAL greater than 87 ng/mL rose to 73.1%, which leaves significant diagnostic uncertainty. Also, the day 1 RAI was an acceptable to good discriminator of the severity of AKI in those identified with AKI: AUC, 0.796 (95% CI, 0.60–0.99); p = 0.019. Conclusions: In our PICU cohort, day 1 uNGAL level greater than 87 ng/mL has good-to-excellent discriminative capacity in identifying AKI, but the diagnostic uncertainty of AKI remains.

6 March 2026
Verified
Journal Article
Open access
AJAna Rita Jesus
Ana Rita Jesus
AFAna Rita Fradique
Ana Rita Fradique
CTCatarina Teixeira
Catarina Teixeira
LCLeonor Carvalho
Leonor Carvalho
TDTeresa Dionísio
Teresa Dionísio
Pediatric Acute Limb Ischemia (ALI) is a rare condition, sometimes encountered in the Intensive Care Unit (ICU). Optimal treatment remains to be established. Topical nitroglycerin has been suggested as a vasodilator agent, used to improve limb reperfusion. We performed a retrospective descriptive study, with data from a PICU of a tertiary hospital, from 2021 to 2024. Seven children presented with ALI treated with topical nitroglycerin, with a median age of 244 days. Wrongful arterial catheterization was established as the cause of ALI in four out of seven children. Six out of seven children showed at least partial recovery. Complete recovery was achieved in three children. Three children underwent partial or total amputation. No adverse side effects were recorded. Topical nitroglycerin appears to be a beneficial and safe intervention in children with ALI.

8 January 2026 in Epileptic Disorders
Verified
Journal Article
Open access
JNJoão Filipe Nico
João Filipe Nico
AFAna Rita Fradique
Ana Rita Fradique
CTCatarina Teixeira
Catarina Teixeira
RMRita Moinho
Rita Moinho
MMMariana Leitão Marques
Mariana Leitão Marques
CPCristina Pereira
Cristina Pereira